ليست عنوان مقالات لاتين Plasma endothelin-1 levels after coronary stenting in humans Plasmachemical oxygenation of porous polymer surfaces for stable hydrophilicity and enhanced liquid absorption

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Plasma endothelin-1 levels after coronary stenting in humans

2

Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms, ,

3

Plasma endothelin-1 levels in patients with left-to-right shunt with or without pulmonary hypertension

4

Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis

5

Plasma endothelin-I and total insulin exposure in diabetes mellitus

6

Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis

7

Plasma energy transport to an electrically biased surface

8

Plasma enhanced aerosol–gel deposition of Al2O3 coatings

9

Plasma enhanced atomic layer deposition of copper: A comparison of precursors

10

Plasma enhanced atomic layer deposition of magnesium oxide as a passivation layer for enhanced photoluminescence of ZnO nanowires

11

Plasma enhanced catalytic reforming of biomass tar model compound to syngas

12

Plasma enhanced chemical vapor deposition of low dielectric constant SiCFO thin films

13

Plasma enhanced chemical vapor deposition of silicon thin films for large area electronics

14

Plasma enhanced chemical vapor deposition of TiO2 films on silica gel powders at atmospheric pressure in a circulating fluidized bed reactor

15

Plasma enhanced chemical vapor deposition of ZnO thin films

16

Plasma enhanced chemical vapour deposition of BCxNy films prepared from N-trimethylborazine: Modelling, synthesis and characterization

17

Plasma enhanced chemical vapour deposition of silica onto titanium: Analysis of surface chemistry, morphology and hydroxylation

18

Plasma enhanced chemical vapour deposition of SiO N in an x y integrated distributed electron cyclotron resonance reactor

19

Plasma enhanced CVD deposition of titanium oxide for biomedical applications

20

Plasma enhanced CVD of fluorocarbon films by low-pressure dielectric barrier discharge

21

Plasma enhanced CVD of SiOxCyHz thin film on different textile fabrics: Influence of exposure time on the abrasion resistance and mechanical properties

22

Plasma enhanced growth of single walled carbon nanotubes at low temperature: A reactive molecular dynamics simulation Original Research Article

23

Plasma enhanced magnetron sputter deposition of Ti–Si–C–N based nanocomposite coatings

24

Plasma enhanced surface treatments using electron beam-generated plasmas

25

Plasma enhanced-CVD of undoped and fluorine-doped Co3O4 nanosystems for novel gas sensors

26

Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions

27

Plasma environment of a weak comet – Predictions for Comet 67P/Churyumov–Gerasimenko from multifluid-MHD and Hybrid models

28

Plasma environment of comet Wirtanen during its low-activity stage

29

Plasma environment of Jupiter family comets

30

Plasma enzymatic, biochemical and hormonal responses to clove oil, 2-phenoxy ethanol, and MS-222 exposed to Caspian brown trout (Salmo trutta caspius, kessleri)

31

Plasma Equilibrium in Tokamaks

32

Plasma erosion in the Venus nightside ionosphere Original Research Article

33

Plasma esterase activities in young and old patients undergoing open inguinal hernia repair

34

Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography–mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy Original Research Article

35

Plasma estrone sulphate (E1S) and estradiol-17β (E2β) profiles during pregnancy and their relationship with the relaxation of sacrosciatic ligament, and prediction of calving time in Holstein–Friesian cattle

36

Plasma etching and feature evolution of organic low-k material by using VicAddress Original Research Article

37

Plasma etching and plasma physics experiments for the undergraduate microelectronics course

38

Plasma etching of As2S3 films for optical waveguides

39

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

40

Plasma etching of InGaP, AlInP and AlGaP in BCl3 environments

41

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

42

Plasma etching of magnetic multilayers — effect of concurrent UV illumination

43

Plasma etching: principles, mechanisms, application to micro- and nano-technologies

44

Plasma Evolutions Around a Solar Coronal 3D Magnetic Null Point

45

Plasma exchange and hemodialysis for severe manifestations of multiple wasp stings in a child

46

Plasma exchange in Goodpasture syndrome associated with Turner’s syndrome: A case report

47

Plasma exchange in Kawasaki disease

48

PLASMA EXCHANGE IN PATIENTS WITH THE DIAGNOSIS OF GUILLAIN-BARRE SYNDROME: AN EXPERIENCE IN INTENSIVE CARE UNIT

49

Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature

50

Plasma experiments with relevance for the nonlinear behavior of semiconductors

51

Plasma extraction in a capillary-driven microfluidic device using surfactant-added poly(dimethylsiloxane)

52

Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age

53

Plasma facing and high heat flux materials – needs for ITER and beyond

54

Plasma facing components of EAST

55

Plasma fatty acid changes in rats after long term fructose diet administration

56

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

57

Plasma Fatty Acid Composition and 6-Year Incidence of Hypertension in Middle-aged Adults The Atherosclerosis Risk in Communities (ARIC) Study

58

Plasma fatty acid status in Moroccan children: increased lipid peroxidation and impaired polyunsaturated fatty acid metabolism in protein-calorie malnutrition

59

Plasma fatty acids concentrations in postoperative patients with biliary atresia

60

Plasma fatty-acid composition and antioxidant capacity in low birth-weight infants fed formula enriched with n−6 and n−3 long-chain polyunsaturated fatty acids from purified phospholipids

61

Plasma feedback controller reorganisation for ASDEX Upgradeʹs new discharge control and data acquisition system

62

Plasma ferritin and pregnancy outcome, , ,

63

Plasma ferritin, premature rupture of membranes, and pregnancy outcome, , ,

64

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience

65

Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm

66

Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina

67

Plasma fibrinogen concentration in a Chinese population

68

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

69

PLASMA FIBRINOGEN LEVEL IN DIABETICS WITH COMPLICATIONS – A PROSPECTIVE STUDY

70

Plasma fibronectin in French centenarians

71

Plasma Fibronectin in Saliva of Women with History of Miscarriage(s) and Periodontal Disease - a Pilot Study

72

Plasma fibronectin levels in ischemic heart disease

73

Plasma flow across the cusp-magnetosheath boundary under northward IMF Original Research Article

74

Plasma flow measurement in high- and low-field-side SOL and influence on the divertor plasma in JT-60U

75

Plasma flow over an array of particles

76

Plasma flow simulation in an off-plane double bend magnetic filter

77

Plasma flow variations and energetic protons upstream of the earth’s bow shock: A statistical study Original Research Article

78

Plasma flow velocity measurements using a modulated Michelson interferometer

79

Plasma Fluoride Level and Femoral Bone Mineral Density in Post-Menopausal Women

80

Plasma focus assisted damage studies on tungsten

81

Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study

82

Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility

83

Plasma Fractionation in Malaysia

84

Plasma Fractionation Industry Project in Turkey: Country’s Experiences

85

Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine

86

Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet

87

Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study

88

Plasma Free Fatty Acids and Risk of Atrial Fibrillation (from the Cardiovascular Health Study)

89

Plasma free iron and chemotherapy toxicity

90

Plasma frequency approach to estimate the Debye temperature of the ionic crystals and metal alloys Original Research Article

91

Plasma from patients exposed to ischemia reperfusion contains clastogenic factors and stimulates the chemiluminescence response of normal leukocytes

92

Plasma from preeclamptic women increases human endotheial cell prostacyclin production without changes in cellular enzyme activity or mass,

93

Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein

94

Plasma fullerene production from powdered carbon black Original Research Article

95

Plasma functionalization for improving dispersion and interfacial bonding of multi-wall carbon nanotubes in cyanate ester/epoxy nanocomposites

96

Plasma functionalization of polypropylene with acrylic acid

97

Plasma functionalization of silicon carbide crystalline nanoparticles in a novel low pressure powder reactor

98

Plasma functionalization of titanium surface for repulsion of blood platelets

99

Plasma GABA in children and adolescents with mood and behavior diorders

100

Plasma GABA predicts acute response to divalproex in mania

101

Plasma GABA predicts response to divalproex in mania

102

Plasma gasification of sewage sludge: Process development and energy optimization

103

Plasma gasification process: Modeling, simulation and comparison with conventional air gasification

104

Plasma generation of supported metal catalysts Original Research Article

105

Plasma Ghrelin Concentration and Obesity: The Effect of Smoked Drugs

106

Plasma ghrelin level in children with type 1 diabetes mellitus

107

Plasma Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Response to Liquid Phase, Solid Phase, and Meals of Differing Lipid Composition

108

Plasma Glucose Alone Does Not Predict Neurologic Dysfunction in Hypoglycemic Nondiabetic Subjects, ,

109

PLASMA GLUCOSE CONCENTRATION AND LIPID PROFILE IN STREPTOZOTOCIN-INDUCED DIABETIC RATS TREATED WITH EXTRACTS OF TRIPLOCHITON SCLEROXYLON K. SCHUM.

110

Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: A peripheral α-2 adrenoceptor antagonist

111

Plasma glucose, lactate, sodium, and potassium levels in children hospitalized with acute alcohol intoxication

112

Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: The effect of riluzole treatment

113

Plasma glutamine response to enteral administration of glutamine in human volunteers (free glutamine versus protein-bound glutamine)

114

Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity

115

Plasma glutathione S-transferase Alpha 1-1: A more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy, , , ,

116

Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose

117

Plasma Glycosaminoglycans: A new Promising tool for Assessment of Non-Metastatic Renal Cell Carcinoma Patients Following Nephrectomy

118

Plasma gonadotropins and ovarian hormones during the estrous cycle in high compared to low ovulation rate gilts

119

Plasma gossypol dynamics in white-tailed deer: Implications for whole cottonseed as a supplemental feed

120

Plasma grafting montmorillonite/iron oxide composite with β-cyclodextrin and its application for high-efficient decontamination of U(VI)

121

Plasma granulysin concentrations and preeclampsia risk

122

Plasma grid design for optimized filter field configuration for the NBI test facility ELISE

123

Plasma Growth Hormone and Prolactin Levels in Healthy Sedentary Young Men after Short-Term Endurance Training under Hot Environment

124

Plasma heating and current drive systems for the fusion ignition research experiment (FIRE)

125

Plasma Heating by Neutral Beam Injection

126

Plasma heating in the initial phase of solar flares

127

Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province, China

128

Plasma high sensitivity C-reactive protein as a marker of severity in children with diabetic ketoacidosis

129

Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease

130

Plasma homocyst(e)ine, folate and vitamin B12 levels among school children in Taiwan: The Taipei Children Heart Study

131

Plasma homocysteine and all-cause mortality in diabetes

132

Plasma homocysteine and cardiovascular disease mortality

133

Plasma homocysteine and cardiovascular risk factors in African American women

134

Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus

135

Plasma homocysteine and heart disease

136

Plasma homocysteine and its association with carotid intimal-medial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study

137

Plasma homocysteine and S-adenosylmethionine in erythrocytes as determinants of carotid intima-media thickness: different effects in diabetic and non-diabetic individuals: The Hoorn Study

138

Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease

139

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus

140

Plasma homocysteine concentration and blood pressure in young adult African Americans

141

Plasma homocysteine concentration is decreased by dietary intervention

142

Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation, ,

143

Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects

144

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men Original Research Article

145

Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism

146

Plasma homocysteine concentrations do not influence craving in alcohol withdrawal

147

Plasma homocysteine concentrations in a Belgian school-age population

148

Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal

149

PLASMA HOMOCYSTEINE CONCENTRATIONS IN YOUNG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

150

Plasma homocysteine in 80-year-olds: Relationships to medical, psychological and social variables

151

Plasma homocysteine in families of type 1 diabetic patients

152

Plasma homocysteine in subjects with familial combined hyperlipidemia

153

Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients

154

Plasma Homocysteine Is Not Involved in the Thrombotic Risk of (beta)Thalassemia major Patients

155

Plasma Homocysteine Level and Coronary Artery Disease in Type 2 Diabetic Patients without Nephropathy

156

Plasma Homocysteine Level and Its Genotypes as a Risk Factor for Coronary Artery Disease in Patients Undergoing Coronary Angiography

157

Plasma Homocysteine Level and its Relationship to Clinical Profile in Parkinson’s Disease Patients at the Lagos University Teaching Hospital

158

Plasma homocysteine level and the course of ischemic stroke

159

Plasma homocysteine level in cardiac syndrome X and its relation with duke treadmill score

160

Plasma Homocysteine Level in Patients with Behcet’s Disease with or without Thrombosis

161

Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study

162

Plasma homocysteine levels and heart disease

163

Plasma homocysteine levels and heart disease

164

Plasma homocysteine levels and late outcome after coronary angioplasty

165

Plasma homocysteine levels in cardiovascular disease, malaria and protein–energy malnutrition in Sudan

166

Plasma homocysteine levels in cycling, pregnant, and spayed bitches

167

Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper

168

Plasma homocysteine levels in patients with isolated coronary artery ectasia

169

Plasma Homocysteine Measurement with Ion Exchange Chromatography (Jeol Aminotac 500): A Comparison with the Abbott IMx Assay

170

Plasma homocysteine predicts progression of atherosclerosis

171

Plasma homocysteine, methylenetetrahydrofolate reductase genotypes, and age at onset of symptoms of myocardial ischemia

172

Plasma homocysteine, methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women

173

Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal

174

Plasma homovanillic acid concentrations in catatonia

175

Plasma homovanillic acid in the prodromal phase of schizophrenia

176

Plasma homovanillic acid in untreated schizophrenia — relationship with symptomatology and sex

177

Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: Comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance

178

Plasma homovanillic acid profile at different phases of the ovulatory cycle in healthy women

179

Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling

180

Plasma hydrophilic surface treatment for dehumidifying heat exchangers

181

Plasma hydroxyurea determined by gas chromatography–mass spectrometry

182

Plasma IGF-2 Concentration and Tissue Expression in Dogs with Malignant Mammary Tumor

183

Plasma IGF-I levels and cognitive performance in older women

184

Plasma IL-10 Concentration and Its Role in the Pathogenesis of Acute Myeloid Leukemia: a Prospective Study

185

Plasma imaging and spectroscopy diagnostics developed on 100-500-kA pulsed power devices

186

Plasma immersion ion implantation based on glow discharge with electrostatic confinement of electrons

187

Plasma immersion ion implantation experiments at the Instituto Nacional de Pesquisas Espaciais (INPE), Brazil

188

Plasma immersion ion implantation experiments with long and short rise time pulses using high voltage hard tube pulser

189

Plasma immersion ion implantation for shallow junctions in silicon

190

Plasma immersion ion implantation in arc and glow discharge plasmas submitted to low magnetic fields

191

Plasma immersion ion implantation induced improvements of mechanical properties, wear resistance, and adhesion of diamond-like carbon films deposited on tool steel

192

Plasma immersion ion implantation into cylindrical bore using internal inductively-coupled radio-frequency discharge

193

Plasma immersion ion implantation of cold-work steel

194

Plasma immersion ion implantation of complex-shaped objects: an experimental study on the treatment homogeneity

195

Plasma immersion ion implantation of cylindrical bore using self-excited radio-frequency glow discharge

196

Plasma immersion ion implantation of industrial gears

197

Plasma immersion ion implantation of insulating materials

198

Plasma immersion ion implantation of nitrogen in Si: formation of SiO2, Si3N4 and stressed layers under thermal and sputtering effects

199

Plasma immersion ion implantation of nitrogen on austenitic stainless steel at variable energy for enhanced corrosion resistance

200

Plasma immersion ion implantation of poly(tetrafluoroethylene)

201

Plasma immersion ion implantation of polymers and silver–polymer nano composites

202

Plasma immersion ion implantation of TiAl using chlorine containing plasma

203

Plasma immersion ion implantation treatment of medical implants

204

Plasma immersion ion implantation using polymeric substrates with a sacrificial conductive surface layer

205

Plasma immersion ion implantation using titanium and oxygen ions

206

Plasma immersion ion implantation—a fledgling technique for semiconductor processing

207

Plasma immersion ion implanted Ti–B-based coatings: Tribological behaviour at room and high temperatures

208

Plasma immersion low-energy-ion bombardment of naked DNA

209

Plasma immersion N and N+C implantation into high-speed tool steel: surface morphology, phase composition and mechanical properties

210

Plasma immersion nitrogen implantation into silicon and rapid thermal electron beam annealing for surface structuring

211

Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome

212

Plasma immunoreactive endothelin-1 levels in hypertensive rats and human subjects

213

Plasma impurity content, gas fueling, and exhaust on DIII-D over extended periods between boronizations

214

Plasma in a high-frequency electric field with a reflective condition on the boundary

215

Plasma in Saturnʹs nightside magnetosphere and the implications for global circulation

216

Plasma inactivation of Escherichia coli cells by atmospheric pressure air brush-shape plasma

217

Plasma induced effects within the bulk material of wood veneers

218

Plasma induced grafting of PSt onto titanium dioxide powder. II

219

Plasma induced patterning of polydimethylsiloxane surfaces

220

Plasma induced sp2 to sp3 transition in boron nitride

221

Plasma Influence of Surface Texture of Silicone Rubber for Biomedical Application in Scala Tympani

222

Plasma Inorganic Iodine and Thyroxine Concentrations for Beef Cows in Late Pregnancy and Early Lactation Associated with Different Levels of Dietary Iodine Supplementation

223

Plasma Insulin and Carotid Intima Media Thickness in Hypertensive and Non Hypertensive Type 2 Diabetics

224

Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice

225

Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men

226

Plasma Insulin-like Growth Factor 1 Distribution and Its Relation to Blood Pressure in Adolescents : The Bogalusa Heart Study

227

Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside

228

Plasma insulin-like growth factor-1 elevated in mild-to-moderate but not severe heart failure

229

Plasma interaction processes during the pulsed laser deposition of superconducting thin films

230

Plasma interaction with liquid lithium: Measurements of retention and erosion

231

Plasma interactions of exoplanets with their parent star and associated radio emissions

232

Plasma interactions with the outboard chamber wall in DIII-D

233

PLASMA INTERFERENCE IN AN ENZYME-LINKED IMMUNOSORBANT ASSAY USING A COMMERCIAL MATCHED ANTIBODY PAIR

234

Plasma interferometry and how the bound-electron contribution can bend fringes in unexpected ways

235

Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6

236

Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure

237

Plasma Interleukin-1β and Tumor Necrosis Factor Concentrations in Obsessive–Compulsive Disorders

238

Plasma interleukin-2 levels and thyroid function in elderly patients with nonthyroidal illness

239

Plasma interleukin-22 and its cellular receptor (IL-22RA1) expression in chronic lymphocytic leukemia

240

Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis Original Research Article

241

Plasma interleukin-6 is associated with psychological coronary risk factors: Moderation by use of multivitamin supplements

242

Plasma intrusion above Mars crustal fields—Mars Express ASPERA-3 observations

243

Plasma ion composition measurements for Europa

244

Plasma Iron Indices in Pregnant Women Referred to the University of Abuja Teaching Hospital, Nigeria

245

Plasma iron is associated with lipid peroxidation in an elderly population

246

PLASMA IRON IS ASSOCIATED WITH LIPID PEROXIDATION IN WOMEN

247

Plasma irradiation effects in phthalocyanine films

248

Plasma jet imaging by CCD technology in rapid mold manufacturing

249

Plasma jet impacts on Citrinin production in isolates belonging to Penicillium Spp.

250

Plasma jet treatment of five polymers at atmospheric pressure: surface modifications and the relevance for adhesion

251

Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease

252

Plasma l-arginine is markedly reduced in pregnant women affected by preeclampsia

253

Plasma LDL subtype distribution in patients with or without coronary stenosis

254

Plasma lens experiment at the final focus test beam

255

Plasma lens experiment at the final focus test beam

256

Plasma lens focusing and plasma channel transport for heavy ion fusion

257

Plasma lens formation in eγ and γγ colliders

258

Plasma leptin and adiponectin concentrations in postmenopausal women with breast cancer following aerobic exercise

259

Plasma Leptin and its Relationship with Lipid Peroxidation and Nitric Oxide in Obese Female Patients with or without Hypertension

260

Plasma leptin and prognosis in patients with established coronary atherosclerosis Original Research Article

261

Plasma Leptin Concentration in Cord Blood: Relationship to the Degree of Preeclampsia and Placental Weight

262

Plasma leptin concentration in migraine; the relationship with orexinergic nerve function

263

Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry

264

Plasma leptin concentrations during the reproductive cycle in the native Thai chicken (Gallus domesticus)

265

Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training

266

PLASMA LEPTIN CONCENTRATIONS IN PRETERM INFANTS WITH RETINOPATHY OF PREMATURITY (ROP)

267

Plasma leptin in growing lambs as a potential predictor for carcass composition and daily gain

268

Plasma leptin levels and inflammation biomarkers in well nourished and malnourished haemodialysed patients

269

Plasma leptin levels in children with cyanotic and acyanotic congenital heart disease and correlations with growth parameters

270

Plasma leptin levels in patients with burn injury: a preliminary report

271

Plasma leptin, ghrelin and adiponectin concentrations in young fit racehorses versus mature unfit standardbreds

272

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

273

Plasma Level Monitoring of Oxcarbazepine in Epileptic Patients

274

Plasma level of adhesion molecules in patients suffering from stable and unstable angina

275

Plasma Level of Antioxidant Vitamins and Lipid Peroxidation in Breast Cancer Patients

276

Plasma Level of Glucagon-like Peptide 1 in Obese Egyptians with Normal and Impaired Glucose Tolerance

277

Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma

278

Plasma Level of miRNA7, miRNA409 and miRNA93 as Potential Biomarkers for Colorectal Cancer

279

Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus

280

Plasma Level of Oxidized Low- Density Lipoprotein in Macroalbuminuric Type 2 Diabetic Patients versus Normoalbuminuric Group

281

Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin Original Research Article

282

Plasma level of trace elements in patients with oral lichen planus

283

Plasma level of vitamin C in women with pre-eclampsia in Ardabil, Iran

284

Plasma levels and hepatic mRNA expression of transforming growth factor-β1 in patients with fulminant hepatic failure

285

Plasma levels and profiles of dioxin and dioxin-like compounds in Ontario Great Lakes anglers

286

Plasma levels of 15-F2t-isoprostane in newborn infants are affected by mode of delivery

287

Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s disease

288

Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy

289

Plasma levels of a low-dose constant-rate-infusion of ketamine and its effect on single and repeated nociceptive stimuli in conscious dogs

290

Plasma levels of adiponectin and soluble thrombomodulin in hypothyroid patients with normal thyroid function following levothyroxine replacement therapy

291

Plasma levels of adrenomedullin in patients with mitral stenosis, , ,

292

Plasma Levels of Adrenomedullin in Primary and Secondary Pulmonary Hypertension in Patients <20 Years of Age

293

Plasma levels of amino acids and hypermetabolism in patients with chronic obstructive pulmonary disease

294

Plasma Levels of Anabolic Hormones in Suckling Lambs are Affected by Late Gestational Nutrition

295

Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: An epidemiological study

296

Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity

297

Plasma levels of atrial natriuretic peptide in severe burn injury

298

Plasma levels of beta-amyloid (1–42) in Alzheimerʹs disease and mild cognitive impairment

299

Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis, ,

300

Plasma Levels of Brain Natriuretic Peptide in Children With Left-To-Right Shunt Before and After Cardiac Surgery

301

Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise

302

Plasma levels of chemokines during leprosy specific treatment

303

Plasma levels of copper, manganese and selenium in an adult population in southern Spain: Influence of age, obesity and lifestyle factors Original Research Article

304

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis

305

Plasma levels of DDT and their association with reproductive hormones in adult men from northern Thailand

306

Plasma levels of endothelin-1 and thrombomodulin in burn patients

307

Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure

308

Plasma levels of fibrinogen as a pathogenic factor or risk indicator of atherosclerosis

309

Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity

310

Plasma levels of heat shock protein 72 (HSP72) and β-endorphin as indicators of stress, pain and prognosis in horses with colic

311

Plasma Levels of IFN-γ, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis

312

Plasma levels of IL-6 and TNF-α in patients with esophageal cancer

313

Plasma Levels of Interleukin 12 Family Cytokines and Their Relevant Cytokines in Adult Patients with Chronic Immune Thrombocytopenia before and after High-Dose Dexamethasome Treatment

314

Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease

315

Plasma levels of interlukin-4 and Interferon- in patients with chronic or healed cutaneous leishmaniasis

316

Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?

317

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

318

Plasma levels of lipophilic antioxidant vitamins in acute ischemic stroke patients: correlation to inflammation markers and neurological deficits

319

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

320

Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers

321

Plasma Levels of MicroRNA-146a-5p, MicroRNA-24-3p, and MicroRNA-125a-5p as Potential Diagnostic Biomarkers for Rheumatoid Arthris

322

Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis

323

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome

324

Plasma levels of miR-29a and miR-146a in relation to carotid intima media thickness measurement for detection of carotid atherosclerosis

325

Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease

326

Plasma levels of N-telopeptide of Type I collagen in periodontal health, disease and after treatment

327

Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction

328

Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques

329

Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion

330

Plasma levels of resistin-like molecule beta in humans

331

Plasma levels of sex steroids (testosterone, progesterone and 17β-estradiol) in Rohu Carp Labeo rohita broodstock from Khuzestan, Iran

332

Plasma levels of soluble endothelial protein C-receptor in patients with β-thalassemia

333

Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha

334

Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease Original Research Article

335

Plasma levels of soluble transferrin receptors and Clara cell protein (CC16) during bipolar mania and subsequent remission

336

Plasma Levels of Soluble Tumor Necrosis Factor Receptor Type I During the Acute Phase Following Complicated Myocardial Infarction Predicts Survival in High-Risk Patients Original Research Article

337

Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity

338

Plasma levels of the antioxidant selenium and risk of myocardial infarction among U.S. physicians

339

Plasma Levels of the Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 are Elevated in Patients with Acute Myocardial Infarction

340

Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects

341

Plasma levels of thrombomodulin in pulmonary hypertension

342

Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Correlated With the Presence of Transplant Coronary Artery Disease in Cardiac Transplant Recipients

343

Plasma Levels of Troponin T After Electrical Cardioversion of Atrial Fibrillation and Flutter

344

Plasma levels of type II phospholipase A2 and nitrite/nitrate in patients with burns

345

Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, flt1, in haematological cancers: A comparison with breast cancer

346

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension

347

Plasma levels of vascular endothelial growth factor and its soluble receptor in non-alcoholic fatty liver disease

348

Plasma Levels of Vascular Endothelial Markers in Obstructive Sleep Apnea

349

Plasma Levels of Viro-Immunological Markers in HIV-Infected and Noninfected Ethiopians: Correlation with Cell Surface Activation Markers

350

Plasma levels of vitamin E in Parkinsonʹs disease

351

Plasma levels of vitellogenin and eggshell zona radiata proteins in 4-nonylphenol and o,p′-DDT treated juvenile Atlantic salmon (Salmo salar)

352

Plasma levels of β-endorphin, leucine enkephalin and arginine vasopressin in patients with essential hypertension and the effects of clonidine

353

Plasma LH concentrations after administration of human chorionic gonadotropin to estrous mares

354

Plasma Liner with an Intermediate Heavy Shell and Thermal Pressure Drive

355

Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension

356

Plasma lipid changes after supplementation with (beta)-glucan fiber from yeast

357

Plasma lipid levels in Alzheimer’s disease patients treated by Donepezil hydrochloride: a cross-sectional study

358

Plasma lipid levels in patients with acute bacterial infections

359

Plasma Lipid Levels in Patients with Cataract, with and without Pseudoexfoliation Syndrome

360

Plasma lipid modifications in elderly people after administration of two virgin olive oils of the same variety (Olea europaea var. hojiblanca) with different triacylglycerol composition

361

Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease

362

Plasma lipid pattern and red cell membrane structure in β-thalassemia patients in Jakarta

363

Plasma Lipid Peroxidation and Total Antioxidant Status among Dyslipidaemic and Hypertensive Nigerians with High Risk of Coronary Heart Disease

364

Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients

365

Plasma Lipid Profile in Non-Diabetic Rats Treated with Extracts of Triplochiton Scleroxylon K. Schum

366

Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan — a unique experience Original Research Article

367

Plasma lipid regulatory effect of compounded freshwater clam hydrolysate and Gracilaria insoluble dietary fibre

368

Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment

369

Plasma lipids and apolipoproteins in a population of Orang Asli (‘aboriginesʹ) from West Malaysia

370

Plasma lipids and cardiovascular risk: a POSCH report

371

Plasma lipids and their role in disease, Edited by Philip J. Barter and Kerry-Anne Rye, Harwood Academic Publishers, 1999. ISBN: 90-5702-466-7; US$120

372

Plasma lipids are altered in Gaucher disease: Biochemical markers to evaluate therapeutic intervention

373

Plasma lipids relationship with results of Oral Glucose Challenge Test in pregnancy

374

Plasma lipids, clotting factors and cardiovascular risk

375

Plasma lipophilic antioxidants and malondialdehyde in congestive heart failure patients: relationship to disease severity

376

Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease re sulting from alcohol abuse: effects of alcohol intake cessa tion : Camps J.; Pizarro, I.; Prats, E.; La Ville A.; Turner, P. R.; Masana, L.; Joven, J. J. Hepatol. 20:7

377

Plasma lipoprotein composition, apolipoprotein(a) concentration and isoforms in β-thalassemia

378

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin Original Research Article

379

Plasma lipoprotein fatty acids are altered by the positional distribution of fatty acids in infant formula triacyiglycerols and human milk

380

Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis

381

Plasma lipoprotein responses to enzyme-replacement in Gaucherʹs disease

382

Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)

383

Plasma Lipoprotein-associated Phospholipase A2 Is Inversely Correlated with Proprotein Convertase Subtilisin-kexin Type 9

384

Plasma Lipoproteins and Atherosclerosis: Accomplishments and Opportunities

385

Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women

386

Plasma low-density lipoprotein immobilized silica as stationary phase in nano-liquid chromatography

387

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: A randomized prospective study

388

Plasma Malondialdehyde and Obesity: Is there a Relationship?

389

Plasma malondialdehyde is induced by smoking: a study with balanced antioxidant profiles

390

Plasma mannan-binding lectin kills microorganisms

391

Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats

392

Plasma maser effect in magnetosphere plasma associated with MHD turbulence

393

Plasma material interaction studies on low activation materials used for plasma facing or blanket component

394

Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery Disease

395

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

396

Plasma melatonin and cortisol in patients with obsessive–compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms

397

Plasma melting and useful application of molten slag

398

Plasma membrane cholesterol plays a critical role in the Salmonella-induced anti-inflammatory response in intestinal epithelial cells

399

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

400

Plasma Membrane Depolarization Induced by Abscisic Acid in Arabidopsis Suspension Cells Involves Reduction of Proton Pumping in Addition to Anion Channel Activation, Which Are Both Ca2+ Dependent

401

Plasma membrane depolarization reduces nitric oxide (NO) production in P388D.1 macrophage-like cells during Leishmania major infection

402

Plasma membrane depolarization-activated calcium channels, stimulated by microtubule-depolmerizing drugs in wild-type Arabidopsis thaliana protoplasts, display constitutively large activities and a longer half-life in ton 2 mutant cells affected in the or

403

Plasma membrane functionalization using highly fusogenic immune activator liposomes

404

Plasma membrane H+-ATPase, succinate and isocitrate dehydrogenases activities of vessel-associated cells in walnut trees

405

Plasma membrane ion channels in suicidal cell death

406

Plasma Membrane Is the Primary Site of Localization of the Nonactivated Estrogen Receptor in the Goat Uterus: Hormone Binding Causes Receptor Internalization

407

Plasma membrane lipid alterations induced by cold acclimation and abscisic acid treatment of winter wheat seedlings differing in frost resistance

408

Plasma membrane NADH oxidase is gravi-responsive

409

Plasma membrane NADH oxidase of maize roots responds to gravity and imposed centrifugal forces

410

Plasma membrane permeabilization by trains of ultrashort electric pulses

411

Plasma Membrane Receptors for Exopolysaccharides of the Ring Rot Causal Agent in Potato Cells

412

Plasma Membrane Redox System in the Erythrocytes of Rowers: Pilot Study

413

Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes

414

Plasma Membrane Reshaping during Endocytosis Is Revealed by Time-Resolved Electron Tomography

415

Plasma membrane segregation during T cell activation: probing the order of domains

416

Plasma membrane transport in context — making sense out of complexity

417

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

418

Plasma membrane γ-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells

419

Plasma membrane-associated endothelial nitric oxide synthase and activity in aging rat aortic vascular endothelia markedly decline with age

420

Plasma Membrane-porating Domain in Poliovirus 2B Protein. A Short Peptide Mimics Viroporin Activity

421

Plasma metabolism of apoB-containing lipoproteins in patients with hepatic lipase deficiency

422

Plasma Metabolite Profiles of Healthy Volunteers after Administration of a Thai Herbal Formula for Dizziness

423

Plasma metabolites and nitrogen balance in Lama glama associated with forage quality at altitude

424

Plasma Metalloproteinase-12 and Tissue Inhibitor of Metalloproteinase-1 Levels and Presence, Severity, and Outcome of Coronary Artery Disease

425

Plasma met-enkephalin levels: its relationship with age and type of headache

426

Plasma met-enkephalin, β-endorphin and leu-enkephalin levels in human hepatic encephalopathy

427

Plasma methane conversion in the presence of carbon dioxide using dielectric-barrier discharges

428

Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia Original Research Article

429

Plasma microcirculation in alveolar capillaries: Effect of parachute-shaped red cells on gas exchange

430

Plasma microRNA profiles for bladder cancer detection

431

Plasma microRNA profiles for bladder cancer detection

432

Plasma microRNAs as non-invasive biomarkers in bovine endometritis caused by Gram-negative and Gram-positive bacteria

433

Plasma mixing as a cause of solar wind magnetic field variations Original Research Article

434

Plasma modeling for position and current control in FTU

435

Plasma modelisation and control for laser dismantling

436

Plasma modelling of matrix assisted UV laser desorption ionisation (MALDI)

437

Plasma Modes of Low-Dimensional Electron Systems over a Helium Film

438

Plasma modification of polycarbonates

439

Plasma modification of polylactic acid in a medium pressure DBD

440

Plasma modification of polypropylene surfaces and its alloying with styrene in situ

441

Plasma modification of self-assembled structures of CoTMPP molecules

442

Plasma modifications of porous PEEK–WC–PU membranes Original Research Article

443

Plasma modified polymers as a support for enzyme immobilization 1.: Allyl alcohol plasma

444

Plasma modified polymers as a support for enzyme immobilization II. Amines plasma

445

Plasma molding over surface topography: Simulation and measurement of ion fluxes, energies and angular distributions over trenches in RF high density plasmas

446

Plasma molybdenum reflects dietary molybdenum intake

447

Plasma multivariable robust control system design and simulation for a thermonuclear tokamak-reactor

448

Plasma Myeloperoxidase Activity and Apolipoprotein A-1 Expression in Chronic Hepatitis B Patients

449

Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure

450

Plasma n-3 and n-6 polyunsaturated fatty acids association with blood pressure level in healthy males

451

Plasma nanostructuring of porous polymer membranes

452

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

453

Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction

454

Plasma Nesfatin-1 and Insulin Resistance Changes Immediately After Circuit-Resistance Exercise and During Recovery Periods in Healthy Men

455

Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals

456

Plasma neuropeptide Y and total- and LDL-cholesterol are closely correlated in women without evident relation to the metabolic syndrome.

457

Plasma Neuropeptide Y Concentrations in Combat Exposed Veterans: Relationship to Trauma Exposure, Recovery from PTSD, and Coping

458

Plasma neuropeptide-Y concentrations in humans exposed to military survival training

459

Plasma neurotransmitters, blood pressure, and heart rate during supine resting, orthostasis, and moderate exercise in dysthymic depressed patients

460

Plasma neurotransmitters, blood pressure, and heart rate during supine-resting, orthostasis, and moderate exercise conditions in major depressed patients

461

Plasma Neutrophil Gelatinase Associated Lipocalin in Neonates With and Without Sepsis

462

Plasma neutrophil gelatinase-associated lipocalin (NGAL) and plasma cystatin C (CysC) as biomarker of acute kidney injury after cardiac surgery

463

Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker for Prediction of 3-Month Graft Survival after Kidney Transplantation

464

Plasma Neutrophil Gelatinase–Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults: The Rancho Bernardo Study

465

Plasma Niobium Surface Alloying of Pure Titanium and its Oxidation at 900 °C

466

Plasma Nitric Oxide and Acute Phase Proteins after Moderate and Prolonged Exercises

467

Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain

468

Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction

469

Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia

470

Plasma nitridation of a novel Ni–10.8 wt.%Cr nanocomposite Original Research Article

471

Plasma nitridation of aluminized high purity iron

472

Plasma nitridation of aluminized high purity iron Original Research Article

473

Plasma nitridation of Ge(100) surface studied by scanning tunneling microscopy

474

Plasma nitrided and TiCN coated AISI H13 steel by pulsed dc PECVD and its application for hot-working dies

475

Plasma nitrided austenitic stainless steels for automotive hydrogen applications

476

Plasma nitriding and in situ characterisation of aluminium

477

Plasma nitriding and nitrocarburising of sintered FeCrMo and FeCrMoC alloys

478

Plasma Nitriding Behavior of DIN 1.2344 Hot Work Tool Steel

479

Plasma nitriding behavior of low carbon binary alloy steels

480

Plasma nitriding behavior of Ti6Al4V orthopedic alloy

481

Plasma nitriding of 316L austenitic stainless steel: Experimental investigation of fatigue life and surface evolution

482

Plasma nitriding of 42CrMo low alloy steels at anodic or cathodic potentials

483

Plasma nitriding of 90CrMoV8 tool steel for the enhancement of hardness and corrosion resistance

484

Plasma nitriding of AISI 304 austenitic stainless steel with pre-shot peening

485

Plasma nitriding of AISI 304 stainless steel: Role of surface mechanical attrition treatment

486

Plasma nitriding of AISI 316L austenitic stainless steels at anodic potential

487

Plasma nitriding of Al alloys by DC glow discharge

488

Plasma nitriding of austenitic stainless steel in N2 and N2–H2 dc pulsed discharge

489

Plasma nitriding of Fe-Cr-Mo sintered steels

490

Plasma nitriding of Fe-Cr-Mo sintered steels

491

Plasma nitriding of low alloy steels at floating and cathodic potentials

492

Plasma nitriding of plastic mold steel to increase wear- and corrosion properties

493

Plasma nitriding of sintered AISI 316L at several temperatures

494

Plasma nitriding of Ti6Al4V alloy and AISI M2 steel substrates using D.C. glow discharges under a triode configuration

495

Plasma nitriding to selective laser sintering parts made of SCM430 powder

496

Plasma nitriding using high H2 content gas mixtures for a cavitation erosion resistant steel

497

Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans

498

Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals

499

Plasma nitrite reserve and endothelial function in the human forearm circulation

500

Plasma nitrites as an indicator of nitric oxide production: Unchanged production or reduced renal clearance in preeclampsia?

501

Plasma Nitroso Compounds Are Decreased in Patients With Endothelial Dysfunction Original Research Article

502

Plasma nitrosulfurizing techniques for low friction coefficient with H2S and C3H8 gas addition

503

Plasma non-cholesterol sterols

504

Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder

505

Plasma norepinephrine and prediction of outcome in major depressive disorder

506

Plasma norepinephrine kinetics in patients with posttraumatic stress disorder

507

Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagasʹ heart disease

508

Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression

509

Plasma N-Terminal B-Type Natriuretic Peptide as an Indicator of Long-Term Survival After Acute Myocardial Infarction: Comparison With Plasma Midregional Pro-Atrial Natriuretic Peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Origin

510

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction

511

Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea

512

Plasma N-terminal pro-brain natriuretic peptide level as a marker of adverse outcome in patients with co-existing diabetes, chronic kidney disease and heart failure

513

Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention

514

Plasma N-Terminal Prohormone Brain Natriuretic Peptide as a Marker for Postoperative Cardiac Events in High-Risk Patients Undergoing Noncardiac Surgery

515

Plasma NT-PRO BNP concentrations are associated with ambulatory blood pressure in black hypertensive patients with normal systolic function on echocardiography

516

Plasma NT-pro BNP Concentrations in Patients with Hypertensive Chronic Kidney Disease

517

Plasma Obestatin Concentrations Are Negatively Correlated with Body Mass Index, Insulin Resistance Index, and Plasma Leptin Concentrations in Obesity and Anorexia Nervosa

518

Plasma obestatin, estradiol, and liver ATP concentrations in response to endurance exercise training at different durations in male rats

519

Plasma oestradiol and progesterone during early pregnancy in the cow and the effects of treatment with buserelin

520

Plasma oestrogen and the regulation of egg weight in laying hens by dietary fats

521

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking

522

Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans

523

Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension

524

Plasma operation and control

525

Plasma operation with tungsten tiles at the central column of ASDEX Upgrade

526

Plasma optical emission spectroscopy diagnostic during amorphous silicon thin films deposition by Rf sputtering technique

527

Plasma oscillations in nanotubes and the Aharonov-Bohm effect for plasmons

528

Plasma osmolality in acute spontanious intra-cerebral hemorrhage: Does it influence hematoma volume and clinical outcome?

529

Plasma Osteopontin and Interleukin-18 Levels in Patients with Systemic Lupus Erythematosus: Association with Disease Activity and Lupus Nephritis

530

Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma

531

Plasma osteopontin levels are associated with the presence and extent of coronary artery disease

532

Plasma Osteopontin Levels Are Higher in Patients With Primary Aldosteronism Than in Patients With Essential Hypertension

533

Plasma over-treatment effect on the MOCVD-TiN contact glue layer

534

Plasma oxidation of bilayered Y/Zr films

535

Plasma oxidation of the insulation layer in the magnetic tunneling junctions

536

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

537

Plasma oxynitrocarburizing of 40Cr steel in an atmosphere of gasoline and air

538

Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin

539

Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial

540

Plasma oxytocin levels in autistic children

541

Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances

542

Plasma parameter investigation during plasma-enhanced chemical vapor deposition of silicon-containing diamond-like carbon films

543

Plasma parameter measurements and deposition of a-Si:H thin films in pulsed ECR plasma.

544

Plasma parameters in pulsed laser-plasma deposition of thin films

545

Plasma parameters of an arc cathode spot at the low-current vacuum discharge

546

Plasma parameters of argon and argon/molecular gas mixture plasmas produced in microwave discharge

547

Plasma paraoxonase, sphingosine1phosphate, total sialic acid, and heat shock protein27 in the liver of the sheep naturally infected with Cysticercus tenuicollis: Evidence on pathological changes

548

Plasma particles dispersion based on Bogoyavlensky-Konopelchenko mathematical model

549

Plasma paste boronizing of AISI 8620, 52100 and 440C steels

550

Plasma PBDE and thyroxine levels in rats exposed to Bromkal or BDE-47 Original Research Article

551

Plasma penetration depth and mechanical properties of atmospheric plasma-treated 3D aramid woven composites

552

Plasma performance improvements with liquid lithium limiters in CDX-U

553

Plasma peroxidation and α-tocopherol levels in women fed different monoene oils

554

Plasma persistence of 2-aminothiazoline-4-carboxylic acid in rat system determined by liquid chromatography tandem mass spectrometry

555

PLASMA PHARMACOKINETICS AND MUSCLE DISPOSITION OF MARBOFLOXACIN IN CHICKENS

556

Plasma pharmacokinetics and tissue distribution study of physalin D in rats by ultra-pressure liquid chromatography with tandem mass spectrometry

557

Plasma pharmacokinetics of melamine and a blend of melamine and cyanuric acid in rainbow trout (Oncorhynchus mykiss)

558

Plasma pharmacokinetics of pioglitazone following oral or intravenous administration in Holstein cows

559

Plasma pharmacokinetics of warfarin enantiomers in cats

560

Plasma phase oxidation during preparation of oxide superconducting and ferroelectric thin films using pulsed laser deposition

561

Plasma phospholipid fatty acid pattern in severe liver disease

562

Plasma phospholipid fatty acid status and depressive symptoms: Association only present in the clinical range

563

Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus

564

Plasma pinch for final focus and transport

565

Plasma pinch for final focus and transport

566

Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity

567

Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis

568

Plasma plume induced during ArF laser ablation of hydroxyapatite

569

Plasma plume photography and spectroscopy of Fe—Oxide materials

570

Plasma polymer coating in a triode glow discharge

571

Plasma polymer films and their future prospects

572

Plasma polymer films as an alternative to (PSS-PAH)n or (PSS-PDADMAC)n films to retain active enzymes in exponentially growing polyelectrolyte multilayers

573

Plasma polymer thin film depositions to regulate gas permeability through nanoporous track etched membranes

574

Plasma polymerisation of methylphenylsilane

575

Plasma polymerization in a microcapillary using an atmospheric pressure dielectric barrier discharge

576

Plasma polymerization of amine-containing thin films and the studies on the deposition kinetics

577

Plasma polymerization of C4Cl6 and C2H2Cl4 at atmospheric pressure

578

Plasma polymerization of hexamethyldisiloxane: Investigation of the effect of carrier gas related to the film properties

579

Plasma polymerization of hybrid organic–inorganic monomers in an atmospheric pressure dielectric barrier discharge

580

Plasma polymerization of styrene with carbon dioxide under glow discharge conditions

581

Plasma polymerization using a constricted anode plasma source

582

Plasma polymerized allylamine films deposited on 316L stainless steel for cardiovascular stent coatings

583

Plasma polymerized barrier films on membranes for direct methanol fuel cells

584

Plasma polymerized ferrocene films

585

Plasma polymerized hexamethyl disiloxane in adhesion applications

586

Plasma polymerized hexamethyldisiloxane (HMDS) barrier layers

587

Plasma polymerized TEOS films for nanochannels formation and sensor development

588

Plasma polymerized thiophene: molecular structure and electrical properties

589

Plasma polymers with chemically defined structures in contact with metals

590

Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: A significant relationship

591

Plasma porphyrin concentrations in chronic renal failure

592

Plasma position and current control system enhancements for the JET ITER-like wall

593

Plasma position measurement on the Novillo tokamak

594

Plasma post-heparin lipase activities in the HERITAGE family study: the reproducibility, gender differences, and associations with lipoprotein levels

595

Plasma post-oxidation mechanisms of nitrided ferrous alloys

596

Plasma post-oxidation of nitrocarburized SUM 24L steel

597

Plasma post-oxidation process for nitrocarburized layer

598

Plasma potential fluctuations and large quasi-coherent modes observed by a heavy ion beam probe on the JIPP T-IIU tokamak

599

Plasma Potential Measurements by the Heavy Ion Beam Probe Diagnostic in Fusion Plasmas: Biasing Experiments in the TJ-II Stellarator and T-10 Tokamak

600

Plasma powder as cold-set binding agent for meat system: Rheological and Raman spectroscopy study

601

Plasma power source based on a catalytic reaction of atomic hydrogen measured by water bath calorimetry

602

Plasma preconditioning of sapphire substrate for GaN epitaxy

603

Plasma preconditioning of sapphire substrate for GaN epitaxy

604

Plasma Prekallikrein as a Risk Factor for Diabetic Retinopathy

605

Plasma preparation of coal to combustion in power boilers

606

Plasma pressure and the field-aligned currents in the magnetosphere Original Research Article

607

Plasma pressure distribution in the inner magnetosphere and the applicability of Dessler-Parker-Sckopke relation to storm time magnetic disturbance description Original Research Article

608

Plasma pre-treatment and TiO2 coating of PMMA for the improvement of antibacterial properties

609

Plasma pretreatment of the Cu seed layer surface in Cu electroplating

610

Plasma pretreatments for Cu-MOCVD

611

Plasma printing: patterned surface functionalisation and coating at atmospheric pressure

612

Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure

613

Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis

614

Plasma Procalcitonin Levels in Chronic Haemodialysis Patients

615

Plasma process for development of a bulk heterojunction optoelectronic device: A highly sensitive UV detector

616

Plasma processes and film deposition using tetraethoxysilane

617

Plasma processes for wide fabric, film and non-wovens

618

Plasma processes in pulsar magnetospheres

619

Plasma processing for inducing bioactivity in stainless steel orthopaedic screws

620

Plasma processing for surface modification of trivalent chromium as alternative to hexavalent chromium layer

621

Plasma processing of AISI 304 stainless steel using radio frequency hollow cathode discharge

622

Plasma processing of interstellar PAHs into solar system kerogen

623

Plasma processing of materials for medical applications

624

Plasma processing of the Si(0 0 1) surface for tuning SPR of Au/Si-based plasmonic nanostructures

625

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

626

PLASMA PROCESSING OF THIN FILMS OF HIGH TEMPERATURE SUPERCONDUCTORS: DEPOSITION METHODS AND GROWTH ASPECTS

627

Plasma processing: a step towards the production of new grades of carbon black Original Research Article

628

Plasma profile and shape optimization for the advanced tokamak power plant, ARIES-AT

629

Plasma profiles and flows in the high-field side scrape-off layer in Alcator C-Mod

630

Plasma profiles in the inner divertor of ASDEX Upgrade

631

Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1

632

Plasma Profiles of Progesterone and Conceptus Proteins in Cows with Spontaneous Embryonic/Fetal Mortality as Diagnosed by Ultrasonography

633

Plasma progesterone changes and length of oestrous cycle in Rusa Deer (Rusa timorensis)

634

Plasma progesterone concentration depends on sampling site in pigs

635

Plasma progesterone concentration in relation to ovulation rate and embryo yield in Chios ewes superovulated with PMSG

636

Plasma progesterone concentrations during early pregnancy in spring- and autumn-bred ewes

637

Plasma progesterone concentrations in the mid-luteal phase are dependent on luteal size, but independent of luteal blood flow and gene expression in lactating dairy cows

638

Plasma progesterone in alpaca (Lama pacos) during pregnancy, parturition and early postpartum

639

Plasma prolactin response to d-fenfluramine in obsessive—compulsive patients before and after fluvoxamine treatment

640

Plasma prolactin, growth hormone and progesterone concentrations in pseudopregnant, hysterectomized and pregnant goats

641

Plasma properties above coronal active regions inferred from SOHO/UVCS and radio spectrograph observations

642

Plasma properties and stoichiometry of laser-deposited BiSrCaCuO thin films

643

Plasma properties from the multi-wavelength analysis of the November 1st 2003 CME/shock event

644

Plasma properties of a new surface-wave-sustained plasma source under the conditions of depositing DLC films

645

Plasma protein adsorption pattern on characterized ceramic biomaterials

646

Plasma Protein and Aggregation Changes in Diabetic Patients

647

Plasma Protein and Soy Fiber Content Effect on Bologna Sausage Properties as Influenced by Fat Level

648

Plasma Protein Binding and Blood-to-Plasma Ratios of Atractylodin and β-Eudesmol, the Bioactive Compounds from Atractylodes lancea (Thunb.) D.C.

649

Plasma protein binding study of oxybutynin by high-performance frontal analysis

650

Plasma protein glycation status in Pakistan type 2 diabetic patients with or without nephropathy

651

Plasma Protein Hydroperoxides During Aging in Humans: Correlation with Paraoxonase 1 (PON1) Arylesterase Activity and Plasma Total Thiols

652

Plasma Protein Lipofuscin-like Fluorophores in Men with Coronary Artery Disease Treated with Statins

653

Plasma Protein Profile of Lactating Women from Two Primary Health Centers in Jakarta, Indonesia

654

Plasma protein therapies: current and future perspectives

655

Plasma protein variations in monozygotic twins discordant for schizophrenia

656

Plasma Proteins in Acute and Chronic Lung Disease of the Newborn

657

Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer

658

Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease

659

Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill

660

Plasma Pyridoxal 5´-Phosphate Level in Children with Intractable and Controlled Epilepsy

661

Plasma quercetin metabolites: structure–antioxidant activity relationships

662

Plasma radiation distribution and radiation loads onto the vessel during transient events in JET

663

Plasma reactions of N2O on hydrogenated amorphous carbon films by PECVD

664

Plasma recovery after various events in HT-7 superconducting tokamak

665

Plasma reduced folates, reproductive performance, and conceptus development in sows in response to supplementation with oxidized and reduced sources of folic acid

666

Plasma Reforming of Aliphatic Hydrocarbons With CO2

667

Plasma reforming of bio-ethanol for hydrogen rich gas production

668

Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases

669

Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects Original Research Article

670

Plasma renin activity and insulin resistance in African American and white children: the Bogalusa Heart Study

671

Plasma Renin Activity and Plasma Prorenin Are Not Suppressed in Hypertensives Surviving to Old Age

672

Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types

673

Plasma renin activity in the emergency department and its independent association with acute myocardial infarction

674

Plasma renin activity levels in hypertensive persons: their wide range and lack of suppression in diabetic and in most elderly patients

675

Plasma renin activity predicts myocardial infarction/revascularization among hypertensive patients

676

Plasma Renin Activity: A Risk Factor for Myocardial Infarction in Hypertensive Patients

677

Plasma resonance of silver nanoparticles deposited on the surface of submicron silica spheres

678

Plasma response models for current, shape and position control in JET

679

Plasma response to a single dose of dietary (beta)-cryptoxanthin esters from papaya (Carica papaya L.) or non-esterified (beta)-cryptoxanthin in adult human subjects: a comparative study

680

Plasma retinol and tocopherol levels in relation to demographic, lifestyle and nutritional factors of plant origin in Greece

681

Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: A three year longitudinal study

682

Plasma rich in growth factors in dogs: Two sides of the same coin

683

Plasma rotation and structure of the radial electric field in RFX

684

Plasma rotation under a driven radial current in a tokamak

685

Plasma S-100B protein in Chinese patients with schizophrenia: Comparison with healthy controls and effect of antipsychotics treatment

686

Plasma satellites of X-ray lines of ions in a picosecond laser plasma

687

Plasma scattering measurement using a submillimeter wave gyrotron (gyrotron FU-II) as a power source

688

Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis

689

Plasma scenarios, equilibrium configurations and control in the design of FAST

690

Plasma secondary-neutral and secondary-ion mass spectrometry investigations on ceramic/copper powder pellets

691

Plasma seed priming in green cumin: physiological and developmental study

692

Plasma Selenium Concentration and Glutathione Peroxidase Activity in Breast Cancer Patients Before and After Chemotherapy

693

Plasma selenium concentrations in pregnant women in two countries with contrasting soil selenium levels

694

Plasma selenium in preterm and term infants during the first 12 months of life

695

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

696

Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection

697

Plasma selenium levels in healthy blood bank donors in the central-eastern part of Belgium

698

Plasma Selenium Measurements in Subjects from Areas with Contrasting Gastric Cancer Risks in Colombia

699

Plasma selenium status in a group of Australian blood donors and fresh blood components

700

Plasma selenium status in children with iron deficiency anemia

701

Plasma separation and anion adsorption transiently relieve intractable pruritus in primary biliary cirrhosis

702

Plasma sequestration before cardiopulmonary bypass and cell saving contribute to improved outcome in high-risk cardiac surgical patients

703

Plasma Serotonin and Markers of Bone Formation and Bone Resorption in Hemodialysis Patients

704

Plasma sFas and sFas Ligand Levels in Patients With Thrombotic Thrombocytopenic Purpura and in Those With Disseminated Intravascular Coagulation

705

Plasma sheath behavior and ionic wind effect in electric field modified flames

706

Plasma sheet and magnetosheath plasma mixing in LLBL: Case study Original Research Article

707

Plasma sheet coefficient of diffusion: Predictions and observations Original Research Article

708

Plasma sheet heating during substorm and the values of the plasma sheet diffusion coefficient obtained on the base of interball/tail probe observations Original Research Article

709

Plasma sheet oscillations and their relation to substorm development: Cluster and double star TC1 case study Original Research Article

710

Plasma shield dynamics and target erosion in disruption simulation experiments

711

Plasma shielding effect in laser ablation of metallic samples and its influence on LIBS analysis

712

Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain

713

Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker

714

Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

715

Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina

716

Plasma Soluble Osteopontin Concentrations Are Increased in Patients With Rheumatic Mitral Stenosis and Associated With the Severity of Mitral Valve Calcium

717

Plasma source ion implantation using high-power pulsed RF plasma

718

Plasma spheroidization and high temperature stability of lanthanum phosphate and its compatibility with molten uranium

719

Plasma spheroidization of ceramic particles

720

Plasma spheroidization of iron powders in a non-transferred DC thermal plasma jet

721

Plasma spray coating of fly ash pre-mixed with aluminium powder deposited on metal substrates

722

Plasma spray deposition and characterization of strontium zirconate coatings

723

Plasma spray deposition and high temperature characterization of ZrB2–SiC protective coatings

724

Plasma spray deposition of Al-Al2O3 coatings doped with metal oxides: catalytic applications

725

Plasma spray deposition of ultra high temperature ceramics

726

Plasma spray formed near-net-shape MoSi2–Si3N4 bulk nanocomposites—structure property evaluation

727

Plasma spray forming

728

Plasma spray synthesis of La10(SiO4)6O3 as a new electrolyte for intermediate temperature solid oxide fuel cells

729

Plasma spray synthesis of nanomaterial powders and deposits

730

Plasma spray synthesis of nanomaterial powders and deposits

731

Plasma spray synthesis of ultra-fine YSZ powder

732

Plasma sprayed Al2O3/FeCrAl composite coatings for electromagnetic wave absorption application

733

Plasma sprayed and laser engraved field electron emitters

734

Plasma sprayed coatings for RF wave absorption

735

Plasma sprayed composite coatings obtained by liquid injection of secondary phases

736

Plasma sprayed gadolinium zirconate thermal barrier coatings that are resistant to damage by molten Ca–Mg–Al–silicate glass

737

Plasma sprayed hydroxyapatite coatings from nanostructured granules

738

Plasma sprayed hydroxyapatite coatings on titanium substrates Part 1: Mechanical properties and residual stress levels

739

Plasma sprayed hydroxyapatite coatings on titanium substrates Part 2: optimisation of coating properties

740

Plasma sprayed metal supported YSZ/Ni–LSGM–LSCF ITSOFC with nanostructured anode

741

Plasma sprayed Mo–Mo oxide nanocomposites: synthesis and characterization

742

Plasma sprayed steel: Adhesion of an alumina film via a wüstite interlayer

743

Plasma sprayed TiB2–Ni cermet coatings: Effect of feedstock characteristics on the microstructure and tribological performance

744

Plasma sprayed TiO2: The influence of power of an electric supply on particle parameters in the flight and character of sprayed coating

745

Plasma sprayed TiO2: The influence of power of an electric supply on relations among stoichiometry, surface state and photocatalytic decomposition of acetone

746

Plasma sprayed tungsten-based coatings and their performance under fusion relevant conditions

747

Plasma sprayed wollastonite/TiO2 composite coatings on titanium alloys

748

Plasma Spraying and Characterization of Chromium Carbide-Nickel Chromium Coatings

749

Plasma spraying modeling: Particle injection in a time-fluctuating plasma jet

750

Plasma spraying of Al2O3–WO3 composite coatings

751

Plasma spraying of efficient photoactive TiO2 coatings

752

Plasma spraying of functionally graded hydroxyapatite/Ti–6Al–4V coatings

753

Plasma spraying of lanthanum silicate electrolytes for intermediate temperature solid oxide fuel cells (ITSOFCs)

754

Plasma spraying of porous nanostructured TiO2 film

755

Plasma spraying of submicron ceramic suspensions using a continuous ink jet printer

756

Plasma startup by neutral beam injection in the Large Helical Device

757

Plasma status of retinol, α- and γ-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study

758

Plasma status of selected minerals in hypertensive men with and without insulin resistance

759

Plasma sterilization using glow discharge at atmospheric pressure

760

Plasma sterilization using the RF glow discharge

761

Plasma steroid concentrations in relation to reproductive performance in Thoroughbred stallions

762

Plasma steroid concentrations in relation to reproductive performance in Thoroughbred stallions

763

Plasma steroid hormone concentrations and blood flow of the ovarian structures of the female dromedary (Camelus dromedarius) during growth, dominance, spontaneous ovulation, luteinization and regression of the follicular wave

764

Plasma steroid levels in female flounder (Platichthys flesus) after chronic dietary exposure to single polycyclic aromatic hydrocarbons

765

Plasma stream homogeneity in metal plasma immersion ion implantation and deposition

766

Plasma structures and transport in the SOL of the T-10 tokamak

767

Plasma structures at weakly outgassing comets—results from bi-ion fluid analysis

768

Plasma study and deposition of DLC/TiC/Ti multilayer structures using technique combining pulsed laser deposition and magnetron sputtering

769

Plasma study of a moly-oxide-argon discharge bulb

770

Plasma substance P and soluble P-selectin as biomarkers of β-thalassemia induced hypercoagulability

771

Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock

772

Plasma suppression of beam–beam interaction in a muon collider

773

Plasma suppression of beam–beam interaction in a muon collider

774

Plasma surface alloying of spheroidal graphite iron

775

Plasma surface engineering in first wall of tokamak

776

Plasma surface engineering in the automotive industry—trends and future prospectives

777

Plasma surface functionalization and dyeing kinetics of Pan-Pmma copolymers

778

Plasma surface hardening of ASSAB 760 steel specimens with Taguchi optimisation of the processing parameters

779

Plasma surface interaction with tungsten in ASDEX Upgrade

780

Plasma surface modification effects on biodegradability and protein adsorption properties of chitosan films

781

Plasma surface modification of hydrogel thin films

782

Plasma surface modification of nanofiltration (NF) thin-film composite (TFC) membranes to improve anti organic fouling

783

Plasma surface modification of NiTi shape memory alloy

784

Plasma surface modification of poly (d,l-lactic-co-glycolic acid) (65/35) film for tissue engineering

785

Plasma surface modification of poly vinyl chloride for improvement of antibacterial properties

786

Plasma surface modification of polyethylene

787

Plasma surface modification of polyimide films by air glow discharge for copper metallization on microelectronic flex substrates

788

Plasma surface modification of polystyrene and polyethylene

789

Plasma surface modification of TiO2 photocatalysts for improvement of catalytic efficiency

790

Plasma surface modification of titanium by TiB precipitation for biomedical applications

791

Plasma surface modification of titanium for hard tissue replacements

792

Plasma surface modificationas a new approach to protect urinary catheteragainst Escherichia coli biofilmformation

793

Plasma surface modifications of PLLA porous scaffold for bone engineering to improve interactions with marrow stromal cells

794

Plasma surface treatment of artificial orthopedic and cardiovascular biomaterials

795

Plasma surface treatment of poly acrylonitrile/films by fluorocarbon compounds

796

Plasma surface treatment of polyethylene terephthalate films for bacterial repellence

797

Plasma surface treatments of poly(l-lactic acid) (PLLA) and poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV)

798

Plasma synthesis and liquid-phase surface passivation of brightly luminescent Si nanocrystals

799

Plasma synthesis of ammonia with a microgap dielectric barrier discharge at ambient pressure

800

Plasma synthesis of hexagonal-pyramidal graphite hillocks

801

Plasma synthesis of semiconductor nanocrystals for nanoelectronics and luminescence applications

802

Plasma synthesized polysilanes — organic nanostructural materials

803

Plasma technique for the fabrication of a durable functional surface on organic polymers

804

Plasma techniques for the fabrication of polymer electrolyte membranes for fuel cells

805

Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder

806

Plasma testosterone and estrone sulfate concentrations in relation to age in Thoroughbred stallions

807

Plasma Testosterone Level in Male Patients with Metabolic Syndrome

808

Plasma tests of diagnostic mirrors for ITER purposes

809

Plasma texturing for silicon solar cells: From pyramids to inverted pyramids-like structures

810

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report

811

Plasma Thiobarbituric Acid-Reactive Substance Levels in Subclinical Hypothyroidism

812

Plasma thiol-functionalized carbon nanotubes decorated with gold nanoparticles for glucose biosensor

813

Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein

814

Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction

815

Plasma thioredoxin levels in patients with unstable angina

816

Plasma thrombomodulin in atherosclerosis and its risk factors

817

Plasma thrombomodulin values and hepatorenal function in the elderly

818

Plasma Thrombopoietin Concentrations in Response to Platelet Transfusion Therapy

819

Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma

820

Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma

821

Plasma Tissue Factor Plus Activated Peripheral Mononuclear Cells Activate Factors VII and X in Cardiac Surgical Wounds Original Research Article

822

Plasma tissue inhibitor of metalloproteinase-1 is elevated in hypertension

823

Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy

824

Plasma TNF-R1 and insulin concentrations in relation to leptin levels among normal and overweight children

825

Plasma TNF-α Elevation in Biologic Naive Rheumatoid Arthritis Patients Belonging to a Population with New Mutations in TLR4 and CYP51A1 genes without Association with Disease-Related Antibodies Levels

826

Plasma torch generation of carbon supported metal catalysts

827

Plasma torch production of macroscopic carbon nanotube structures Original Research Article

828

Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis

829

Plasma Total Antioxidant Capacity in an Adult Hong Kong Chinese Population

830

Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women

831

Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis

832

Plasma total cholesterol in psychiatric patients after a suicide attempt and in follow-up

833

Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease

834

Plasma Total Homocysteine and Risk of Angina Pectoris With Subsequent Coronary Artery Bypass Surgery

835

Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement

836

Plasma total homocysteine in Mexican rural and urban women fed typical model diets

837

Plasma total homocysteine is not associated with peripheral neuropathy in a groups Bangladeshi type 2 diabetic subjects

838

Plasma total homocysteine levels in postmenopausal women with unstable coronary artery disease

839

Plasma total homocysteine quantification: an improvement of the classical high-performance liquid chromatographic method with fluorescence detection of the thiol-SBD derivatives

840

Plasma Total Protein, Serum Calcium and Inorganic Phosphate Levels in Nigerian Horses with Natural Piroplasmosis

841

Plasma total T3 and T4 concentrations in bucks as affected by photoperiod

842

Plasma total T3 and T4 concentrations in goats at different physiological stages, as affected by the energy intake

843

Plasma total, lipoprotein cholesterol, organs cholesterol and growth performance in rats fed dietary gum arabic

844

PLASMA TRACE ELEMENTS AND COGNITIVE FUNCTION IN OLDER MEN AND WOMEN:THE RANCHO BERNARDO STUDY

845

Plasma trade and the HIV epidemic

846

Plasma transferred arc boriding of a low carbon steel: microstructure and wear properties

847

Plasma transferred arc composite coatings with self lubricating properties, based on Fe and Ti sulfides: Microstructure and tribological behavior

848

Plasma Transferred Arc deposition of powdered high performances alloys: process parameters optimisation as a function of alloy and geometrical configuration

849

Plasma transferred arc surface alloying of a construction steel to produce a metal matrix composite tool steel with TiC as reinforcing particles

850

Plasma transferred arc surface modification of a low carbon steel

851

Plasma transfusion and automated plasmapheresis – possibilities and limitations for veterinary medicine

852

Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats

853

Plasma transport and optical flares in high-density plasmas produced from a pulsed cathodic arc

854

Plasma transport coefficients: An application of SO(3) group

855

Plasma treated activated carbon impregnated with silver nanoparticles for improved antibacterial effect in water disinfection Original Research Article

856

Plasma treated polyethylene grafted with adhesive molecules for enhanced adhesion and growth of fibroblasts

857

Plasma treated polyethylene terephthalate/polypropylene films assembled with chitosan and various preservatives for antimicrobial food packaging

858

Plasma treatment — an increasing technology for paper restoration?

859

Plasma treatment allows water suspending of the natural hydrophobic powder (lycopodium)

860

Plasma treatment effects on hydrogenated amorphous carbon films prepared by plasma-enhanced chemical vapor deposition Original Research Article

861

Plasma treatment effects on Si and Si/dielectric film heterostructures

862

Plasma treatment for fluxless soldering

863

Plasma treatment induced wetting transitions on biological tissue (pigeon feathers)

864

Plasma treatment of air pollution control residues

865

Plasma treatment of bulk niobium surface for SRF cavities

866

Plasma treatment of bulk niobium surface for SRF cavities

867

Plasma treatment of carbon fibers: Non-equilibrium dynamic adsorption and its effect on the mechanical properties of RTM fabricated composites Review Article

868

Plasma treatment of ITO surfaces to improve luminescence characteristics of organic light-emitting devices with dopants

869

Plasma treatment of PDMS for applications of in vitro motility assays

870

Plasma treatment of pitch-based ultra high modulus carbon fibers Original Research Article

871

Plasma treatment of polypropylene and polysulfone supports for thin film composite reverse osmosis membrane

872

Plasma treatment of polypropylene fabric for improved dyeability with soluble textile dyestuff

873

Plasma treatment of SnO2 nanocolumn arrays deposited by liquid injection plasma-enhanced chemical vapor deposition for gas sensors

874

Plasma treatment of the carbon fiber bipolar plate for PEM fuel cell

875

Plasma treatment of the Mg:Ag/tris-(8-hydroxyquinoline) aluminum interface in OLEDs: effects on adhesion and performance

876

Plasma treatment on electrode surfaces of bifacial silicon solar cells

877

Plasma treatment on finger nails prior to coating with a varnish

878

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

879

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease Original Research Article

880

Plasma triglycerides, an independent predictor of cardiovascular disease in men: A prospective study based on a population with prevalent metabolic syndrome

881

Plasma Trypsin Level in Horses Suffering From Acute Intestinal Obstruction

882

Plasma tryptophan during weight restoration in patients with anorexia nervosa

883

Plasma tryptophan levels and prolactin response to fenfluramine in healthy volunteers

884

Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC–tandem mass spectrometry

885

Plasma tumor necrosis factor-α, its soluble receptors and interleukin-1β levels in critically burned patients

886

Plasma turbulence in tokamaks

887

Plasma type II phospholipase A2 levels are elevated in severe preeclampsia,

888

Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia

889

Plasma urea nitrogen in relation to pregnancy rate in dairy sheep

890

Plasma urea-cycle-related amino acids, ammonium levels, and urinary orotic acid excretion in short-bowel patients managed with an oral diet

891

Plasma uridine as well as uric acid is elevated following fructose loading

892

Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease

893

Plasma urotensin II in heart failure

894

Plasma vapor deposition hard coating on pre-nitrided low alloy steel

895

Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate

896

Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction

897

Plasma velocity in interplanetary planar magnetic structures Original Research Article

898

Plasma vertical stabilization in ITER-FEAT

899

Plasma vertical stabilization with actuation constraints in the DIII-D tokamak

900

Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia

901

Plasma Viscosity in Isolated Systolic Hypertension: The Role of Pulse Pressure

902

Plasma vitamin A and E levels in patients with gastroesophageal cancer in Eastern Anatolia

903

Plasma vitamin A and zinc levels in HIV-infected adults in Cape Town, South Africa

904

Plasma vitamin B12, folate and homocysteine levels in gastrectomized men

905

Plasma vitamin C concentration in pregnant women with preeclampsia in Mulago hospital, Kampala, Uganda

906

Plasma Vitamin D level in Patients with SARS-CoV-2 Infection: Does it Correlates With the Increased Risk of Infection?

907

Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population

908

Plasma Vitamin D-Binding Protein and Risk of Heart Failure in Male Physicians

909

Plasma vitellogenin in Moreletʹs crocodiles from contaminated habitats in northern Belize

910

Plasma vitellogenin levels and gonadal morphology of wild carp (Cyprinus carpio L.) in a receiving rivers downstream of Sewage Treatment Plants

911

Plasma volume and electrolyte changes following intravenous infusion of hypertonic hydroxyethyl starch versus mannitol in healthy dogs

912

Plasma Volume Changes With an Acute Bout of High-Intensity Exercise in Men With Chronic Congestive Heart Failure Secondary to Coronary Artery Disease

913

Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease

914

Plasma Volume to Achieve Remission in Atypical Hemolytic Uremic Syndrome

915

Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: The Frederiksberg heart failure study

916

Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation Patients

917

Plasma wake-field acceleration of high energies: Physics and perspectives

918

Plasma wake-field acceleration of high energies: Physics and perspectives

919

Plasma wall interaction during ELMs in JET

920

Plasma wall interaction study in the large helical device

921

Plasma wall interactions in RFX-mod with virtual magnetic boundary

922

Plasma Wave Acceleration of Electron in Bubble Regime in Presence of a Planar Wiggler

923

Plasma waves and electromagnetic radiation at Venus and Mars Original Research Article

924

Plasma waves in a nonideal plasma

925

Plasma waves in two-dimensional conductors with impurity electron states

926

Plasma wind tunnel testing of ultra-high temperature ZrB2–SiC composites under hypersonic re-entry conditions

927

Plasma zinc antioxidant vitamins, glutathione levels and total antioxidant activity in oral leukoplakia

928

Plasma zinc in adults with cystic fibrosis: Correlations with clinical outcomes

929

Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?

930

Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria

931

Plasma α1-antichymotrypsin in Alzheimer’s disease; relationships with APOE genotypes

932

Plasma α-Glutathione S-Transferase Evaluation in Patients with Acute and Chronic Liver Injury

933

Plasma β amyloid and impaired CO2-induced cerebral vasomotor reactivity

934

Plasma β-amyloid peptides levels: A pilot study in bipolar depressed patients

935

Plasma β-endorphin around parturition and its relationship to cortisol level and resumption of pituitary and ovarian functions in dairy cows

936

Plasma β-endorphin levels during liver transplantation in patients with familial amyloidotic polyneuropathy

937

Plasma β-endorphin levels during liver transplantation in patients with familial amyloidotic polyneuropathy

938

Plasma, milk and faecal progesterone concentrations during the oestrous cycle of lactating dairy cows with different milk yields

939

Plasma, plumes and rings: Saturn system dynamics as recorded in global color patterns on its midsize icy satellites

940

Plasma, Serum, and Platelet Expression of CD40 Ligand in Adults With Cardiovascular Disease

941

Plasma, urinary and fecal potassium changes in athletes during ambulatory, periodic, and continuous hypokinetic conditions

942

Plasma, urinary, and salivary 8-epi-prostaglandin F2α levels in normotensive and preeclamptic pregnancies

943

Plasma/blood pharmacokinetics and metabolism after dermal exposure to para-aminophenol or para-phenylenediamine

944

Plasma/thermal-driven the rapid wettability transition on a copper surface

945

Plasma_sprayed components for SOFC applications

946

Plasma-activated core-shell gold nanoparticle films with enhanced catalytic properties

947

Plasma-activated immobilization of biomolecules onto graphite-encapsulated magnetic nanoparticles Original Research Article

948

Plasma-aided hydrogenation and Al-doping: Increasing the conductivity and optical transparency of ZnO transparent conducting oxide

949

Plasma-arc generated light inhibits proliferation and induces apoptosis of human gingival fibroblasts in a dose-dependent manner

950

Plasma-assisted boriding of pure titanium and TiAl6V4

951

Plasma-assisted catalytic methanation of CO and CO2 over Ni–zeolite catalysts

952

Plasma-assisted catalytic reforming of propane and an assessment of its applicability on vehicles

953

Plasma-assisted chemical process for NOx control

954

Plasma-assisted co-evaporation of β-indium sulfide thin films

955

Plasma-assisted CuO/CeO2/TiO2-γ-Al2O3 catalysts for NO + CH4 reaction and NO temperature programmed desorption studies

956

Plasma-assisted ignition for a kerosene fueled scramjet at Mach 1.8

957

Plasma-assisted MBE growth of group-III nitrides: from basics to device applications

958

Plasma-assisted oxidation of carbon particle by lattice oxygen on/in oxide catalyst

959

Plasma-assisted partial oxidation of methane to synthesis gas in a dielectric barrier discharge Original Research Article

960

Plasma-assisted preparation of Fe–Cu bimetal catalyst for higher alcohols synthesis from carbon monoxide hydrogenation

961

Plasma-assisted pre-treatment for PACVD TiN coatings on tool steel

962

Plasma-Assisted Process for Removing NO/NOx from Gas Streams with C2H4 as Additive

963

Plasma-assisted Pt and Pt–Pd nano-particles deposition on carbon carriers for application in PEM electrochemical cells

964

Plasma-assisted pulsed laser deposition for the improvement of the film growth process

965

Plasma-assisted reduction of a NiO/Al2O3 catalyst in atmospheric pressure H2/Ar dielectric barrier discharge

966

Plasma-assisted reduction of supported metal catalyst using atmospheric dielectric-barrier discharge

967

Plasma-assisted self-organized growth of uniform carbon nanocone arrays Original Research Article

968

Plasma-assisted SiC oxidation for power device fabrication

969

Plasma-assisted stabilization of laminar premixed methane/air flames around the lean flammability limit

970

Plasma-assisted surface hardening of dual two-phase intermetallic alloy composed of Ni3X type structures

971

Plasma-assisted surface modification of organic biopolymers to prevent bacterial attachment

972

Plasma-assisted synthesis of Ag/ZnO nanocomposites: First example of photo-induced H2 production and sensing

973

Plasma-assisted synthesis of carbon encapsulated magnetic nanoparticles with controlled sizes correlated to smooth variation of magnetic properties

974

Plasma-assisted synthesis of zinc nanowires

975

Plasma-based carbon ion implantation of aluminium at different process times in a pulse-ignited methane plasma

976

Plasma-based chemical modification of epitaxial graphene with oxygen functionalities

977

Plasma-based ion implantation and its application to three-dimensional materials

978

Plasma-based ion implantation of oxygen in stainless steel: influence of ion energy and dose

979

Plasma-based ion implantation utilising a cathodic arc plasma

980

Plasma-based ion implantation: a valuable industrial route for the elaboration of innovative materials

981

Plasma-based ion process in the dual-plasma configuration

982

Plasma-based low-energy ion implantation for low-temperature surface engineering

983

Plasma-based low-energy ion implantation of austenitic stainless steel for improvement in wear and corrosion resistance

984

Plasma-based nitrogen implantation of chrome-plated steel

985

Plasmablastic lymphoma developing in thyroid: a rare entity in an immunocompetent individual

986

Plasmablastic Lymphoma Mimicking Acute Pancreatitis

987

Plasmablastic Lymphoma presenting as small intestinal polyposis: A case-report

988

Plasmablastic Lymphoma versus Anaplastic Myeloma in a Human Immunodeficiency Virus Negative Male: A Diagnostic Quandary

989

Plasma-carburising — a surface heat treatment process for the new century

990

Plasma-catalyst hybrid methanol-steam reforming for hydrogen production

991

Plasma–catalyst interactions in the treatment of volatile organic compounds and NOx with pulsed corona discharge and reticulated vitreous carbon Pt/Rh-coated electrodes

992

Plasma-cavity ringdown spectroscopy for analytical measurement: Progress and prospectives

993

Plasma-cavity ringdown spectroscopy for analytical measurement: Progress and prospectives

994

Plasma-channel-based reactor and final transport

995

Plasma-channel-based reactor and final transport

996

Plasma-chemical bromination of graphitic materials and its use for subsequent functionalization and grafting of organic molecules Original Research Article

997

Plasmachemical degradation of azo dyes by humid air plasma: Yellow Supranol 4 GL, Scarlet Red Nylosan F3 GL and industrial waste

998

Plasma-Chemical Destruction of Trilaurylamine Issued from Nuclear Laboratories of Reprocessing Plants

999

Plasma–chemical model, describing the surface treatment of polymers in RF-discharge

1000

Plasmachemical oxygenation of porous polymer surfaces for stable hydrophilicity and enhanced liquid absorption

بازگشت